Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Leases: 2014-2025

Historic Leases for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Sep 2025 value amounting to $2.6 million.

  • Viridian Therapeutics, Inc.\DE's Leases rose 416.40% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year increase of 416.40%. This contributed to the annual value of $2.2 million for FY2024, which is 32.04% up from last year.
  • According to the latest figures from Q3 2025, Viridian Therapeutics, Inc.\DE's Leases is $2.6 million, which was up 30.60% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Leases registered a high of $2.6 million during Q3 2025, and its lowest value of $500,000 during Q3 2024.
  • In the last 3 years, Viridian Therapeutics, Inc.\DE's Leases had a median value of $1.9 million in 2023 and averaged $1.8 million.
  • Its Leases has fluctuated over the past 5 years, first surged by 501.50% in 2021, then plummeted by 73.05% in 2024.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Leases (Quarterly) stood at $1.7 million in 2021, then dropped by 4.17% to $1.6 million in 2022, then rose by 3.73% to $1.7 million in 2023, then skyrocketed by 32.04% to $2.2 million in 2024, then surged by 416.40% to $2.6 million in 2025.
  • Its last three reported values are $2.6 million in Q3 2025, $2.0 million for Q2 2025, and $2.1 million during Q1 2025.